Literature DB >> 32894697

Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study.

Christine M Durand1, Brittany Barnaba1, Sile Yu1, Diane M Brown1, Michael A Chattergoon1, Nichole Bair1, Fizza F Naqvi1, Mark Sulkowski1, Dorry L Segev1, Niraj M Desai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32894697      PMCID： PMC8288461          DOI： 10.7326/M20-1468

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

Authors:  David S Goldberg; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Matthew Levine; K Rajender Reddy; Roy D Bloom; Susanna M Nazarian; Deirdre Sawinski; Paige Porrett; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Midhat Farooqi; Caren Gentile; Jennifer Smith; Peter P Reese
Journal:  N Engl J Med       Date:  2017-04-30       Impact factor: 91.245

2.  Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.

Authors:  Ann E Woolley; Steve K Singh; Hilary J Goldberg; Hari R Mallidi; Michael M Givertz; Mandeep R Mehra; Antonio Coppolino; Amanda E Kusztos; Megan E Johnson; Kaiwen Chen; Esther A Haddad; John Fanikos; David P Harrington; Phillip C Camp; Lindsey R Baden
Journal:  N Engl J Med       Date:  2019-04-03       Impact factor: 91.245

3.  Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.

Authors:  Nikhil Kapila; Kawtar Al-Khalloufi; Pablo A Bejarano; Jason M Vanatta; Xaralambos B Zervos
Journal:  Am J Transplant       Date:  2019-09-18       Impact factor: 8.086

Review 4.  Risks, benefits, and ethical questions associated with transplanting kidneys from hepatitis C virus-infected donors into hepatitis C virus-negative patients.

Authors:  David Goldberg; Peter P Reese
Journal:  Semin Dial       Date:  2018-11-26       Impact factor: 3.455

5.  Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.

Authors:  Miklos Z Molnar; Satheesh Nair; Orsolya Cseprekal; Masahiko Yazawa; Manish Talwar; Vasanthi Balaraman; Pradeep S B Podila; Valeria Mas; Daniel Maluf; Ryan A Helmick; Luis Campos; Nosratollah Nezakatgoo; Corey Eymard; Peter Horton; Rajanshu Verma; Ann Holbrook Jenkins; Charlotte R Handley; Heather S Snyder; Carolyn Cummings; Uchenna A Agbim; Benedict Maliakkal; Sanjaya K Satapathy; James D Eason
Journal:  Am J Transplant       Date:  2019-08-02       Impact factor: 8.086

6.  Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.

Authors:  Nikhil Kapila; K V Narayanan Menon; Kawtar Al-Khalloufi; Jason M Vanatta; Carla Murgas; Diego Reino; Samer Ebaid; Joshua J Shaw; Neerja Agrawal; Salwa Rhazouani; Viviana Navas; Cedric Sheffield; Asad Ur Rahman; Michael Castillo; Christina C Lindenmeyer; Charles Miller; Cristiano Quintini; Xaralambos B Zervos
Journal:  Hepatology       Date:  2020-04-15       Impact factor: 17.425

7.  Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients.

Authors:  Gaurav Gupta; Idris Yakubu; Chandra S Bhati; Yiran Zhang; Le Kang; Julie A Patterson; Ayana Andrews-Joseph; Anam Alam; Andrea Ferreira-Gonzalez; Dhiren Kumar; Irfan K Moinuddin; Layla Kamal; Anne L King; Marlon Levy; Amit Sharma; Adrian Cotterell; Trevor W Reichman; Aamir Khan; Pamela Kimball; Rodney Stiltner; Mary Baldecchi; Nathaniel Brigle; Todd Gehr; Richard K Sterling
Journal:  Am J Transplant       Date:  2019-11-15       Impact factor: 8.086

8.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598

9.  Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation.

Authors:  Meghan E Sise; Ian A Strohbehn; Donald F Chute; Jenna Gustafson; Vivianna M Van Deerlin; Jennifer R Smith; Caren Gentile; David Wojciechowski; Winfred W Williams; Nahel Elias; Raymond T Chung
Journal:  Kidney Int Rep       Date:  2020-01-13
  9 in total
  10 in total

Review 1.  Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease.

Authors:  Ian A Strohbehn; Rituvanthikaa Seethapathy; Meghan Lee; Meghan E Sise
Journal:  Kidney360       Date:  2021-05-21

2.  Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis.

Authors:  Zepei Feng; Jinwei Zhang; Weilong Tan; Chunhui Wang; Qiong Chen; Chao Shen; Haozhi Fan; Yun Zhang; Peng Huang; Ming Yue
Journal:  Front Med (Lausanne)       Date:  2022-05-18

3.  Hepatitis C Virus Treatment and Solid Organ Transplantation.

Authors:  Ronit Patnaik; Eugenia Tsai
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-02

4.  Liver Outcome in Renal Transplant Recipients Who Acquired Hepatitis C Infection From an Infected Graft: Study Based on Liver Biopsy Findings.

Authors:  Jiten P Kothadia; Anshul Bhalla; Miklos Z Molnar; Rahul Mohan; Vasanthi Balaraman; Manish Talwar; Ryan Helmick; Corey Eymard; Ian Clark; Richa Jain; Thomas W Faust; Jason M Vanatta; James D Eason; Satheesh P Nair
Journal:  Transplant Direct       Date:  2022-05-26

5.  Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting.

Authors:  Beatrice P Concepcion; Laura A Binari; Heidi Schaefer; Scott Rega; Irene Feurer; Saed Shawar; Ruchi Naik; Laura Hickman; Jasmine Walker; Meghan Kapp; Kelly A Birdwell; Anthony Langone; J Harold Helderman; Bonnie Ann Sarrell; Guneet Kochar; Bernard Dubray; Kristin Smith; Heather O'Dell; April DeMers; Princess Shelton; Roman Perri; David Shaffer; Rachel C Forbes
Journal:  Transplant Direct       Date:  2021-09-07

6.  One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial.

Authors:  Meghan Elizabeth Sise; David Seth Goldberg; Douglas Earl Schaubel; Robert J Fontana; Jens J Kort; Rita R Alloway; Christine M Durand; Emily A Blumberg; E Steve Woodle; Kenneth E Sherman; Robert S Brown; John J Friedewald; Niraj M Desai; Samuel T Sultan; Josh Levitsky; Meghan D Lee; Ian A Strohbehn; J Richard Landis; Melissa Fernando; Jenna L Gustafson; Raymond T Chung; Peter Philip Reese
Journal:  Kidney Int Rep       Date:  2021-12-01

Review 7.  Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?

Authors:  Paulina Czarnecka; Kinga Czarnecka; Olga Tronina; Teresa Baczkowska; Magdalena Durlik
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

Review 8.  Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5.

Authors:  Chen-Hua Liu; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2022-07-25       Impact factor: 9.029

Review 9.  Transplanting Organs from Donors with HIV or Hepatitis C: The Viral Frontier.

Authors:  Brian J Boyarsky; Alexandra T Strauss; Dorry L Segev
Journal:  World J Surg       Date:  2021-01-20       Impact factor: 3.352

10.  Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin-A Randomized Controlled Clinical Trial.

Authors:  Lone W Madsen; Peer B Christensen; Janne F Hansen; Birgit T Røge; Dorte K Holm; Sandra Dröse; Anne Øvrehus
Journal:  Viruses       Date:  2022-03-16       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.